In Vivo Molecular Evidence for Enhanced Chemosensitivity of Pancreatic Cancer Cells to Gemcitabine and Oxaliplatin by Thymoquinone

S. Banerjee,A. Kaseb,Z. Wang,D. Kong,S. Padhaye,R. Mohammad,F. H. Sarkar

DOI: https://doi.org/10.1097/01.mpa.0000335341.28085.c8

2008-01-01

Pancreas

Abstract:Purpose: Pancreatic cancer patients respond very poorly to currently available chemotherapeutic agents partly due to the high degree of inherent and acquired chemo-resistance. We recently reported the potential efficacy of Thymoquinone (TQ), present in the volatile oil of the seed Nigella sativa (also called black cumin seeds) in chemosensitizing pancreatic cancer cells in vitro (Banerjee S et.al. 2008 AACR Annual Meeting, San Diego, Abstract # 712). As corollary to our initial findings, we further investigated whether thymoquinone could sensitize pancreatic tumors to conventional cytotoxic agents in vivo using an orthotopic mouse model of pancreatic cancer. Methods: Female ICR-SCID mice orthotopically implanted with HPAC tumor cells were randomized into 6 treatment groups comprising (n = 5-7): (a) untreated control; (b) TQ only (50 mg/kg b.wt/day orally by gavage for 30 days); (c) gemcitabine alone (50 mg/kg b.wt; 2x/wk.); (d) oxaliplatin alone (5 mg/kg b.wt; 2x/wk.; and (e) TQ followed by gemcitabine/oxaliplatin. Molecular evidence in support of chemosensitization of pancreatic tumors to oral TQ treatment was assessed by performing gel shift assay for NF-κB DNA binding activity, and assessed the expression of NF-κB dependent downstream genes such as survivin and Bcl-xL by Western blot analysis. Additionally, chemosensitization was validated in vivo using non invasive optical imaging of EGF receptor expression as biomarker in addition to tumor weight measured at the time of sacrifice of all the experimental animals. Results: Analysis of average pancreatic tumor weight in different treatment groups revealed that pre-treatment with TQ followed by gemcitabine and/or oxaliplatin resulted in a significant reduction in tumor weight relative to untreated control (p < 0.05) and in single regimen treated animals. In parallel with our in vitro findings, we confirmed in an in vivo animal model the potential of TQ in augmenting down-regulation of NF-κB (which contributes to cytotoxic chemotherapeutic drug induced chemo-resistance), resulting in the sensitization of tumor cell to greater killing by cytotoxic agents. Using non invasive optical imaging of EGF receptor as representative of tumor size, we found that this method yields low tissue auto-fluorescence corroborating other parameters predictive of chemo-sensitization for assessing the therapeutic efficacy of both gemcitabine and oxaliplatin.